CD8A and angiosarcoma: Among patients with angiosarcoma, the presence of CD8 + tumor infiltrating lymphocytes correlates with a survival advantage.138 In addition to CD8 + cells, endothelial malignancies also have infiltration of CD3 + and CD4 + lymphocytes, as well as regulatory FoxP3 lymphocytes.